Rong Lei, Lei Qi, Zhang Xian-Zheng
Key Laboratory of Biomedical Polymers of Ministry of Education & Department of Chemistry, Wuhan University, Wuhan 430072, People's Republic of China.
Institute of Pharmaceutical Sciences, China Pharmaceutical University, Nanjing 210009, People's Republic of China.
ACS Appl Bio Mater. 2020 Dec 21;3(12):8136-8145. doi: 10.1021/acsabm.0c01286. Epub 2020 Nov 18.
Bacteria possess many unique properties in treating cancer that are unachievable with standard methods, including specific tumor targeting, deep tissue penetration, and programmable therapeutic efficacy. Bacteria species such as , , , and have been demonstrated to restrict tumor growth with improved prognosis in mice models. Moreover, some bacterial strains were advanced to clinical trials. This Spotlight on Applications summarizes general strategies for engineering living bacteria to fight cancer and provides examples to illustrate different approaches to engineer bacteria for safety and therapeutic index improvement.
细菌在治疗癌症方面具有许多标准方法无法实现的独特特性,包括特异性肿瘤靶向、深部组织穿透和可编程治疗效果。诸如大肠杆菌、沙门氏菌、李斯特菌和双歧杆菌等细菌物种已被证明在小鼠模型中可抑制肿瘤生长并改善预后。此外,一些菌株已进入临床试验阶段。本应用聚焦总结了改造活细菌对抗癌症的一般策略,并提供实例以说明改造细菌提高安全性和治疗指数的不同方法。